DISCOVER EXPANDED ACCESS PROGRAMS. EARLY ACCESS TO DRUGS IN DEVELOPMENT.

DISCOVER EXPANDED ACCESS PROGRAMS

myTomorrows provides physicians and patients that are excluded from clinical trials access to drugs in development. We focus on disease areas with unmet needs; oncology, neurology, psychiatry and rare diseases.

Expanded Access Programs include treatments for Severe Depression, Primary Liver Cancer (HCC), Chronic Fatigue Syndrome (CFS), Chest Wall Breast Cancer and Peripheral T-cell Lymphoma (Blood Cancer). Sign up at myTomorrows to see all available programs for your country.

SEE ALL PROGRAMS

PROVIDING EARLY ACCESS TO THE LATEST DRUGS IN DEVELOPMENT

expanded access programs

WHAT WE DO

Identify drug developments. Our physicians and bio-medical specialists identify the latest drug developments from across the globe.

Inform. Physicians and pharmacists can register online and request information about the drugs myTomorrows provides access to.

Facilitate requests. In most countries health authorities must grant permission for treatment with a non-registered drug. myTomorrows facilitates requests for permission for physicians and pharmacists.

About us

myTomorrows was founded by physicians and experts from the pharmaceutical and technology industry to provide doctors and patients with access to drugs in development. We serve doctors and patients facing high unmet medical needs who are not eligible for inclusion in clinical trials. In fact, our company name was inspired by a quote from an ALS patient seeking access to not-yet-registered drugs: “I just want some more tomorrows”.

Read more about us here.

DISCOVER MYTOMORROWS

SEE ALL PROGRAMS

WHAT ARE EXPANDED ACCESS PROGRAMS?

Drug development takes about twelve years from discovery to marketing authorization. Drugs that show promising results during clinical development need to be tested in large patient populations before receiving marketing authorization. In many cases patients with high unmet medical needs that are excluded from clinical trials, can’t afford to wait the extra years it takes for a drug to receive such a marketing authorization.

Expanded Access Programs enable physicians and patients who have exhausted other medicinal treatment options to access development stage drugs or drugs that have marketing authorization elsewhere, but not yet in their home country.

LEARN MORE...

dna sequencing genome

BUILDING THE MOST COMPLETE EXPANDED ACCESS PROGRAM DATABASE IN THE WORLD

Search Made Easy

Searching expanded access programd and clinical trials has never been so simple with the myTomorrows Mobile app.

It is free…

IN THE PRESS